Spotlight

Dr Celia Caulcott

UCL launches £50 million technology investment fund

UCL is today launching the UCL Technology Fund to invest £50 million in commercialising its world-leading research emerging over the next five years.

Find out more




follow us on twitter


Dr Celia Caulcott 

Vice-Provost (Enterprise) and Interim Director of UCL Enterprise Operations and UCL Advances

T: +44 (0)20 3108 5072
E: VPEnterprise@ucl.ac.uk

Dr Celia Caulcott

The Office of the Vice-Provost (Enterprise) is responsible for delivering UCL’s Enterprise agenda with the greatest economic and societal impact. Vice-Provosts are members of the Provost's senior management team. Dr Caulcott took up the post at UCL in October 2015.

Before joining UCL, Dr Caulcott was Executive Director, Innovation and Skills at the Biotechnology and Biological Sciences Research Council (BBSRC), where she had responsibility for developing and delivering the BBSRC strategy for innovation. This focused on accelerating the outstanding bioscience research outputs from UK research towards application, building partnerships, in particular with business and industry, and ensuring support for the development of future bioscience researchers for the UK, in industry, academia, policy and elsewhere.

Prior to working for the BBSRC, she worked in and with the biopharmaceuticals industry (including Celltech Ltd, ICI Pharmaceuticals, the Wellcome Foundation and a range of UK early stage biotechs). She has also worked with the Wellcome Trust on the Human Genome Project and for Imperial College London developing research strategy. She has an honours degree in Microbiology and a PhD in pharmaceutical microbiology.